Long-term fluoxetine administration, indeed, not only induces NPAS4 expression [101], but also has been proved successful in promoting the functional recovery from stroke in humans [120], which is a major cause of long-term disability for which there is currently no clinical treatment. Here, NPAS4 is linked to stroke disorder.